Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

Vircell – Varicella Zoster VirClia Monotest IgM and IgG

The Varicella Zoster VirClia Monotest is an indirect chemiluminescent immunoassay to test antibodies against varicella zoster virus in human serum or plasma.

Features of the Varicella Zoster Monotest:

  • Monotest format with ready-to-use reagents.
  • Simple and automated protocol with fast results.
  • Custom setup of samples and reagents.
  • Each monodose includes a calibrator and a negative control that enables the validation and interpretation of results for each individual sample.
  • Allows pipetting from primary sample tube, no further manipulation is needed.
  • Compatible with the VirClia Lotus platform.

 

Learn more about Vircell VirClia Monotest catalogue

Download catalogue >

About Vircell VirClia Lotus

Vircell VirClia Lotus provides a complete, fully automated platform together with self-contained monotests assays with all the needed reagents in the strip including calibrators and controls.

About 90 tests available with compatible protocols, including the Varicella Zoster Monotest, and no special workflow considerations. All different assays can be treated as one.

Learn more about Vircell VirClia Lotus

Read more >

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.

Recent Posts

Fungal Infection – Assays and Controls*

IMMY | Vircell IMMY’s rapid fungal assays and Vircell’s external controls deliver reliable, room temperature diagnostics with built-in quality assurance for streamlined serology workflows. Vircell…

Read full article

Vircell – VirClia Extraction Tube

Discover Vircell’s VirClia Extraction Tube, an innovative pre-dispensed tube featuring a one-step filtering process that eliminates the need for centrifugation, thereby significantly simplifying the pre-analytical…

Read full article

Advancing Sepsis Diagnostics—Journal of Clinical Medicine (JCM), Honors SeptiCyte RAPID* Study

  Immunexpress are delighted to announce that the study, “Validation of SeptiCyte® RAPID to Discriminate Sepsis from Non-Infectious Systemic Inflammation,” has been selected as an Editor’s Choice Paper for 2024 by the Journal of Clinical Medicine (JCM) MDPI Editorial Team. This honour…

Read full article